Users’ Guides to the Medical Literature: VI. How to Use an Overview

JAMA: The Journal of the American Medical Association

Volumn 272, Issue 17, 1994, Pages 1367-1371

  Oxman, Andrew D ^a   Cook, Deborah J ^a   Guyatt, Gordon H ^a   Bass, Eric ^a   Brill Edwards, Patrick ^a   Browman, George ^a   Detsky, Allan ^a   Farkouh, Michael ^a   Gerstein, Hertzei ^a   Haines, Ted ^a   Haynes, Brian ^a   Hayward, Robert ^a   Holbrook, Anne ^a   Jaeschke, Roman ^a   Juniper, Elizabeth ^a   Laupacis, Andreas ^a   Lee, Hui ^a   Levine, Mitchell ^a   Moyer, Virginia ^a   Naylor, David ^a   Nishikawa, Jim ^a   Patel, Ameen ^a   Philbrick, John ^a   Richardson, Scott ^a   Sauve, Stephane ^a   Sacked, David ^a   Sinclair, Jack ^a   Strom, Brian ^a   Trout, K S ^a   Tunis, Sean ^a   Walter, Stephen ^a   Williams, John ^a   Wilson, Mark ^a   more..

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CORONARY RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; DOCTOR PATIENT RELATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MALE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0028126590     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03520170077040     Document Type: Article

References (39)

1. 1. Davey Smith G, Song F, Sheldon TA. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993;306:1367-1373.
2. 2. Silberberg JS, Henry DA. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention, I: a meta-analysis of cholesterol-lowering trials. Med J Aust. 1991; 155:665-666, 669-670.
3. 3. Oxman AD, Sackett DL, Guyatt GH, for the Evidence-Based Medicine Working Group. Users’ guides to the medical literature, I: how to get started. JAMA. 1993;270:2093-2095.
4. 4. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107: 224-233.
5. 5. Sacks HS, Berries J, Reitman D, Arcona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med. 1987;316:450-455.
6. 6. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Can Med Assoc J. 1988;138:697-703.
7. 7. Mulrow CD. The medical review article: state of the science. Ann Intern Med. 1987;106:485-488.
8. 8. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA. 1992;268:240-248.
9. 9. Cochrane AL. 1931-1971: a critical review, with particular reference to the medical profession. In: Medicines for the Year 2000. London, England: Office of Health Economics; 1979:2-12.
10. 10. The Cochrane Collaboration. Oxford, England: UK Cochrane Centre, National Health Service Research and Development Programme; 1994. Brochure.
11. 11. Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, eds. Cochrane Pregnancy and Childbirth Database [derived from the Cochrane Database of Systematic Reviews], Cochrane Updates on Disk, Update Software. Oxford, England: UK Cochrane Centre; 1993: disk issue 2.
12. 12. Chalmers TC, Berrier J, Sacks HS, et al. Meta-analysis of clinical trials as a scientific discipline, II: replicate variability and comparison of studies that agree and disagree. Stat Med. 1987;6:733-744.
13. 13. Gøtzsche PC. Reference bias in reports of drug trials. BMJ. 1987;295:654-656.
14. 14. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ. 1992;305:15-19.
15. 15. Cook DJ, Guyatt GH, Ryan G, et al. Should unpublished data be included in meta-analyses? current convictions and controversies. JAMA. 1993; 269:2749-2753.
16. 16. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990; 263:1385-1389.
17. 17. Dickersin K, Min Y-I, Meinert CL. Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. JAMA. 1992;267:374-378.
18. 18. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867-872.
19. 19. Dickersin K, Min Y-I. NIH clinical trials and publication bias. Online J Curr Clin Trials [serial online]. April 28, 1993;50.
20. 20. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J R Stat Soc. 1988;151:445-463.
21. 21. Williamson JW, Goldschmidt PG, Colton T. The quality of medical literature: analysis of validation assessments. In: Bailar JC, Mosteller F, eds. Medical Uses of Statistics. Waltham, Mass: NEJM Books; 1986:370-391.
22. 22. Horwitz RI. Complexity and contradiction in clinical trial research. Am J Med. 1987;82:498-510.
23. 23. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe A. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol. 1992;45:255-265.
24. 24. Chalmers TC, Celano P, Sacks HS, Smith H. Bias in treatment assignment in controlled trials. N Engl J Med. 1983;309:1358-1361.
25. 25. Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 1987;6:223-240.
26. 26. Yusuf S, Wiftes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93-98.
27. 27. Oxman AD, Guyatt GH. A consumer's guide to subgroup analysis. Ann Intern Med. 1992;116:78-84.
28. 28. Glass GV, McGaw B, Smith ML. Meta-analysis in Social Research. Newbury Park, Calif: Sage; 1981:18-20.
29. 29. Cooper RM, Rosenthal R. Statistical versus traditional procedures for summarizing research findings. Psychol Bull. 1980;87:442-449.
30. 30. Guyatt GH, Sackett DL, Cook DJ, for the Evidence-Based Medicine Working Group. Users’ guides to the medical literature, II: how to use an article about therapy or prevention, B: what were the results and will they help me in caring for my patients? JAMA. 1994;271:59-63.
31. 31. Jaeschke R, Guyatt GH, Sackett DL, for the Evidence-Based Medicine Working Group. Users’ guides to the medical literature, III: how to use an article about a diagnostic test, B: what are the results and will they help me in caring for my patients? JAMA. 1994;271:703-707.
32. 32. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318: 1728-1733.
33. 33. Rosenthal R. Meta-analytic Procedures for Social Research. 2nd ed. Newbury Park, Calif: Sage; 1991.
34. 34. Smith K, Cook DJ, Guyatt GH, Mudhaven J, Oxman AD. Respiratory muscle training in chronic airflow limitation: a meta-analysis. Am Rev Respir Dis. 1992;145:533-539.
35. 35. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
36. 36. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990;301:309-314.
37. 37. Davey Smith G, Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? BMJ. 1992;304:431-434.
38. 38. Law MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994;308:373-379.
39. 39. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367-373.